Skip to main content

Table 5 Rates and types of VTE prophylaxis based on diagnosis

From: Venous thromboembolism risk and prophylaxis in the acute hospital care setting: report from the ENDORSE study in Egypt

Type of diagnosis

Any Px received N

Any anticoagula

GCS w/o anticoagulant/IPC

ACCP Px received

ACCP anticoagulant

ACCP GCS w/o anticoagulant/IPC

 

(%)

ntn (%)*

n (%)*

N (%)

n (%)*

n (%)*

Surgical Patients at VTE Risk

      

Hip replacement

0 (0.0%)

0 (0.0%)

0 (0.0%)

0 (0.0%)

0 (0.0%)

0 (0.0%)

Knee replacement

1 (50.0%)

1 (100.0%)

0 (0.0%)

0 (0.0%)

0 (0.0%)

0 (0.0%)

Hip fracture

6 (100.0%)

6 (100.0%)

0 (0.0%)

6 (100.0%)

6 (100.0%)

0 (0.0%)

Curative arthroscopy

0 (0.0%)

0 (0.0%)

0 (0.0%)

0 (0.0%)

0 (0.0%)

0 (0.0%)

Other ortho trauma

13 (56.5%)

13 (100.0%)

0 (0.0%)

11 (47.8%)

11 (100.0%)

0 (0.0%)

Colon/small bowel

8 (42.1%)

8 (100.0%)

0 (0.0%)

8 (42.1%)

8 (100.0%)

0 (0.0%)

Rectosigmoid

4 (100.0%)

3 (75.0%)

1 (25.0%)

3 (75.0%)

3 (100.0%)

0 (0.0%)

Gastric

4 (50.0%)

4 (100.0%)

0 (0.0%)

4 (50.0%)

4 (100.0%)

0 (0.0%)

Hepatobiliary

7 (21.2%)

6 (85.7%)

1 (14.3%)

7 (21.2%)

6 (85.7%)

1 (14.3%)

Urologic

5 (26.3%)

5 (100.0%)

0 (0.0%)

5 (26.3%)

5 (100.0%)

0 (0.0%)

Vascular

6 (54.5%)

5 (83.3%)

1 (16.7%)

6 (54.5%)

5 (83.3%)

1 (16.7%)

Thoracic

2 (50.0%)

2 (100.0%)

0 (0.0%)

2 (50.0%)

2 (100.0%)

0 (0.0%)

Gynecologic

5 (50.0%)

5 (100.0%)

0 (0.0%)

5 (50.0%)

5 (100.0%)

0 (0.0%)

Other surgery

22 (28.2%)

20 (90.9%)

1 (4.5%)

20 (25.6%)

20 (100.0%)

0 (0.0%)

Major trauma but surgery not performed

3 (33.3%)

3 (100.0%)

0 (0.0%)

3 (33.3%)

3 (100.0%)

0 (0.0%)

Medical Patients at VTE Risk

      

Acute heart failure (NYHA Class III or IV)

12 (40.0%)

11 (91.7%)

0 (0.0%)

9 (30.0%)

9 (100.0%)

0 (0.0%)

Ischemic stroke

12 (63.2%)

12 (100.0%)

0 (0.0%)

12 (63.2%)

12 (100.0%)

0 (0.0%)

Hemorrhagic stroke

2 (66.7%)

2 (100.0%)

0 (0.0%)

2 (66.7%)

2 (100.0%)

0 (0.0%)

Other cardiovascular disease

36 (57.1%)

34 (94.4%)

0 (0.0%)

32 (50.8%)

32 (100.0%)

0 (0.0%)

Hematologic disease

0 (0.0%)

0 (0.0%)

0 (0.0%)

0 (0.0%)

0 (0.0%)

0 (0.0%)

Malignancy (active)

0 (0.0%)

0 (0.0%)

0 (0.0%)

0 (0.0%)

0 (0.0%)

0 (0.0%)

Acute non-infectious respiratory disease

4 (16.7%)

3 (75.0%)

1 (25.0%)

3 (12.5%)

3 (100.0%)

0 (0.0%)

Pulmonary infection

22 (29.7%)

20 (90.9%)

0 (0.0%)

20 (27.0%)

20 (100.0%)

0 (0.0%)

Infection (non-respiratory)

3 (25.0%)

3 (100.0%)

0 (0.0%)

2 (16.7%)

2 (100.0%)

0 (0.0%)

Rheumatotologic/Inflammatory

1 (25.0%)

1 (100.0%)

0 (0.0%)

1 (25.0%)

1 (100.0%)

0 (0.0%)

Neurologic

3 (37.5%)

3 (100.0%)

0 (0.0%)

3 (37.5%)

3 (100.0%)

0 (0.0%)

Renal

7 (35.0%)

7 (100.0%)

0 (0.0%)

7 (35.0%)

7 (100.0%)

0 (0.0%)

Endocrine/Metabolic

19 (44.2%)

17 (89.5%)

0 (0.0%)

17 (39.5%)

17 (100.0%)

0 (0.0%)

GI/Hepatobiliary

5 (20.8%)

5 (100.0%)

0 (0.0%)

5 (20.8%)

5 (100.0%)

0 (0.0%)

Other medical condition

2 (50.0%)

2 (100.0%)

0 (0.0%)

2 (50.0%)

2 (100.0%)

0 (0.0%)

  1. Abbreviations: VTE = venous thromboembolism, Px = prophylaxis, IPC = intermittent pneumatic compression, GCS = graduted compression stockings, w/o = without, ACCP = American College of Chest Physicians, NYHA = New York Heart Association, GI = gastrointestinal* The denominator is patients who received prophylaxis
  2. IPC without Anticoagulation n = 0.
  3. ACCP IPC w/o Anticoagulant n = 0.